Current Assets Zmiana Data
Amgen USD 30.33B 18.14B 2023-12
AstraZeneca USD 22.5B 338M 2023-09
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Celldex Therapeutics USD 431.69M 185.76M 2023-12
Eli Lilly USD 23.01B 1.68B 2023-09
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
Intrexon USD 92.99M 12.64M 2023-09
Lumos Pharma USD 47.45M 8.54M 2023-09
MannKind USD 373.39M 147.82M 2023-12
Merck USD 31.95B 1.98B 2023-09
Minerva Neurosciences USD 48.22M 4M 2023-09
Novavax USD 1.01B 120.79M 2023-09
Peregrine Pharmaceuticals USD 104.2M 5.89M 2023-09
Repligen USD 978.46M 20.13M 2023-09
Roche Holding CHF 30.98B 2.84B 2023-06
Xencor USD 623.16M 51.98M 2023-12



Peregrine Pharmaceuticals Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.